Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
345.84 USD | +1.39% | -0.01% | +57.16% |
EPS & Dividend: United Therapeutics Corporation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Dividend per Share 2 | - | - | - | - | - | - | - | - |
Rate of return | - | - | - | - | - | - | - | - |
EPS 2 | -2.39 | 11.54 | 10.06 | 15 | 19.81 | 24.75 | 27.33 | 27.83 |
Distribution rate | - | - | - | - | - | - | - | - |
Reference price 2 | 88.08 | 151.79 | 216.08 | 278.09 | 219.89 | 341.11 | 341.11 | 341.11 |
Nbr of stocks (in thousands) | 43,881 | 44,441 | 45,037 | 45,577 | 46,994 | 44,491 | - | - |
Announcement Date | 20-02-26 | 21-02-24 | 22-02-24 | 23-02-22 | 24-02-21 | - | - | - |
Upcoming events: United Therapeutics Corporation
2024-10-29 | Q3 2024 Earnings Release (Projected) |
2025-02-18 | Q4 2024 Earnings Release (Projected) |
2025-04-29 | Q1 2025 Earnings Release (Projected) |
2025-07-29 | Q2 2025 Earnings Release (Projected) |
Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
---|---|---|---|---|---|---|
-.--% | -.--% | 13.78x | 2.041 | 4.54x | ||
+0.85% | +0.98% | 47.3x | 4.061 | 6.28x | ||
-.--% | -.--% | 30.94x | 6.211 | 3.57x | ||
-.--% | -.--% | -108.03x | 125.85 | 14.53x | ||
+0.26% | +0.26% | 75.9x | 2.399 | 11.57x | ||
-.--% | -.--% | -7.59x | 2.548 | 6.14x | ||
-.--% | -.--% | 32.41x | 2.470 | 3.19x | ||
+0.44% | +0.46% | 60.93x | 4.976 | 9.46x | ||
-.--% | -.--% | 29.77x | 11.21 | 4.65x | ||
-.--% | -.--% | 50.4x | 2.731 | 5.28x | ||
Average | +0.15% | +0.17% | 22.58x | 16.45 | 6.92x | |
Weighted average by Cap. | +0.20% | +0.23% | 17.91x | 20.31 | 7.16x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
MarketScreener is also available in this country: United States.
Switch edition